InspireMD (NSPR) Cash from Financing Activities (2010 - 2025)

InspireMD has reported Cash from Financing Activities for 15 years, with the latest figure at $52.9 million in Q3 2025.

• For the quarter ending Q3 2025, Cash from Financing Activities rose 5584.56% year-over-year to $52.9 million; the trailing twelve-month figure through Dec 2025 stood at $55.6 million (up 9192.47% YoY), and the FY2025 full-year result was $55.6 million, up 201.15% from the prior year.
• Cash from Financing Activities for Q3 2025 stood at $52.9 million, up from $2.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $52.9 million in Q3 2025, with the low at -$965000.0 in Q3 2024.
• Historically, Cash from Financing Activities has averaged $10.1 million across 4 years, with a median of $506000.0 in 2025.
• Annual changes were most pronounced in 2021 — Cash from Financing Activities surged 1168833.33% — and 2022, when it plunged 194.29%.
• InspireMD's Cash from Financing Activities stood at -$35000.0 in 2021, then sank by 194.29% to -$103000.0 in 2022, then jumped by 1617.48% to $1.6 million in 2024, then jumped by 3286.18% to $52.9 million in 2025.
• The last three Cash from Financing Activities figures came in at $52.9 million (Q3 2025), $2.1 million (Q2 2025), and $506000.0 (Q1 2025), per Business Quant data.